Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 1.22 B1.28 B1.27 B1.33 B1.24 B1.32 B 5.15 B Research & development —————— — Operating income 987 M923 M1.06 B-152 M1.06 B1.06 B 3.03 B Non-Operating Income, Total 94 M46 M39 M35 M64 M75 M 213 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 68 M29 M25 M11 M40 M34 M 110 M Unusual income/expense 26 M17 M14 M24 M24 M41 M 103 M Pretax income 775 M629 M734 M796 M775 M793 M 3.1 B Equity in earnings —————— — Taxes 182 M199 M154 M161 M169 M175 M 659 M Non-controlling/minority interest 8 M-55 M001 M0 1 M After tax other income/expense —————— — Net income before discontinued operations 585 M485 M580 M635 M605 M618 M 2.44 B Discontinued operations 006 M2 M—— — Net income 585 M485 M586 M637 M605 M618 M 2.45 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 585 M485 M586 M637 M605 M618 M 2.45 B Basic earnings per share (Basic EPS) 1.030.861.041.131.081.1 4.35 Diluted earnings per share (Diluted EPS) 1.020.861.041.121.071.1 4.33 Average basic shares outstanding 568.5 M563 M562.1 M564 M561.8 M560.8 M — Diluted shares outstanding 571.1 M565.4 M564.7 M566.7 M564.1 M563 M — EBITDA 1.37 B1.3 B1.44 B226 M1.42 B1.43 B 4.51 B EBIT 987 M923 M1.06 B-153 M1.06 B1.06 B 3.03 B Cost of revenue 1.94 B2.06 B2.16 B2.34 B2.04 B2.14 B 8.67 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 383 M384 M372 M379 M359 M369 M 1.48 B